基本信息:
- 专利标题： TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS
- 申请号：PCT/US2021/026654 申请日：2021-04-09
- 公开(公告)号：WO2021207650A1 公开(公告)日：2021-10-14
- 发明人： NIYIKIZA, Clet , MOYO, Victor, Mandla
- 申请人： L.E.A.F. HOLDINGS GROUP LLC
- 申请人地址： 326 Overlook Lane
- 专利权人： L.E.A.F. HOLDINGS GROUP LLC
- 当前专利权人： L.E.A.F. HOLDINGS GROUP LLC
- 当前专利权人地址： 326 Overlook Lane
- 代理机构： HOOVER, Kenley, K.
- 优先权： US63/007,884 2020-04-09
- 主分类号： A61B9/00
- IPC分类号： A61B9/00 ; A61K31/194 ; A61K31/202 ; A61K36/88 ; A61K47/40 ; A61P9/00
摘要：
Trans-crocetin pharmaceutical compositions, dosing regimens and methods of treating or preventing disorders and conditions associated with, but not limited to, infection, ischemia, hypoxia, ARDS, inflammation, sepsis, shock, stroke, traumatic injury, and proliferative disorders such as cancer are provided. Methods of using the provided trans-crocetin pharmaceutical compositions and dosing regimens to treat cardiovascular, renal, liver, inflammatory, metabolic, pulmonary, neurological, and other disorders and conditions are also provided, as are methods of increasing the delivery of oxygen and increasing the efficacy of a therapeutic agent using the provided compositions and dosing regimens.